
    
      Patients with breast cancer receiving anthracycline chemotherapy randomized to 3
      groups:chemotherapy plus low dose dexrazoxane,chemotherapy plus middle dose dexrazoxane,
      chemotherapy only.Every patient receive at least 2 cycles anthracycline chemotherapy.
    
  